Ito E - Search Results

1

Efficacy of combining GMX1777 with radiation therapy for human head and neck carcinoma.

Kato H, Ito E, Shi W, Alajez NM, Yue S, Lee C, Chan N, Bhogal N, Coackley CL, Vines D, Green D, Waldron J, Gullane P, Bristow R, Liu FF. Kato H, et al. Among authors: ito e. Clin Cancer Res. 2010 Feb 1;16(3):898-911. doi: 10.1158/1078-0432.CCR-09-1945. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103674

2

Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.

Yip KW, Ito E, Mao X, Au PY, Hedley DW, Mocanu JD, Bastianutto C, Schimmer A, Liu FF. Yip KW, et al. Among authors: ito e. Mol Cancer Ther. 2006 Sep;5(9):2234-40. doi: 10.1158/1535-7163.MCT-06-0134. Mol Cancer Ther. 2006. PMID: 16985057

3

Increased efficiency for performing colony formation assays in 96-well plates: novel applications to combination therapies and high-throughput screening.

Katz D, Ito E, Lau KS, Mocanu JD, Bastianutto C, Schimmer AD, Liu FF. Katz D, et al. Among authors: ito e. Biotechniques. 2008 Feb;44(2):ix-xiv. doi: 10.2144/000112757. Biotechniques. 2008. PMID: 18422490 Free article.

4

On the path to seeking novel radiosensitizers.

Katz D, Ito E, Liu FF. Katz D, et al. Among authors: ito e. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):988-96. doi: 10.1016/j.ijrobp.2008.12.002. Int J Radiat Oncol Biol Phys. 2009. PMID: 19251086 Review.

5

Therapeutic efficacy of seliciclib in combination with ionizing radiation for human nasopharyngeal carcinoma.

Hui AB, Yue S, Shi W, Alajez NM, Ito E, Green SR, Frame S, O'Sullivan B, Liu FF. Hui AB, et al. Among authors: ito e. Clin Cancer Res. 2009 Jun 1;15(11):3716-24. doi: 10.1158/1078-0432.CCR-08-2790. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470731

6

Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer.

Ito E, Yip KW, Katz D, Fonseca SB, Hedley DW, Chow S, Xu GW, Wood TE, Bastianutto C, Schimmer AD, Kelley SO, Liu FF. Ito E, et al. Mol Pharmacol. 2009 Nov;76(5):969-83. doi: 10.1124/mol.109.055277. Epub 2009 Aug 4. Mol Pharmacol. 2009. PMID: 19654225

7

Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.

Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E, Busson P, Lo KW, Ng R, Waldron J, O'Sullivan B, Liu FF. Shi W, et al. Among authors: ito e. Int J Cancer. 2010 May 1;126(9):2036-48. doi: 10.1002/ijc.24880. Int J Cancer. 2010. PMID: 19739117

8

Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma.

Gerster K, Shi W, Ng B, Yue S, Ito E, Waldron J, Gilbert R, Liu FF. Gerster K, et al. Among authors: ito e. Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):253-60. doi: 10.1016/j.ijrobp.2009.11.027. Int J Radiat Oncol Biol Phys. 2010. PMID: 20394857

9

Nasopharyngeal carcinoma: the next challenges.

Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B, Chan K. Razak AR, et al. Among authors: ito e. Eur J Cancer. 2010 Jul;46(11):1967-78. doi: 10.1016/j.ejca.2010.04.004. Epub 2010 May 5. Eur J Cancer. 2010. PMID: 20451372 Review.

10

Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.

Ito E, Yue S, Moriyama EH, Hui AB, Kim I, Shi W, Alajez NM, Bhogal N, Li G, Datti A, Schimmer AD, Wilson BC, Liu PP, Durocher D, Neel BG, O'Sullivan B, Cummings B, Bristow R, Wrana J, Liu FF. Ito E, et al. Sci Transl Med. 2011 Jan 26;3(67):67ra7. doi: 10.1126/scitranslmed.3001922. Sci Transl Med. 2011. PMID: 21270338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,392 results

Search Page

Filters